Young David 4
4 · Processa Pharmaceuticals, Inc. · Filed Jan 29, 2025
Insider Transaction Report
Form 4
Young David
DirectorPres. Research & Development
Transactions
- Purchase
Common Stock
2025-01-27$0.80/sh+124,500$99,289→ 205,405 total
Holdings
- 18,544(indirect: By LLC)
Common Stock
- 30,985(indirect: By Trust)
Common Stock
- 10,786(indirect: By Family Entities)
Common Stock